SARS CoV-2 (COVID-19) Current Pharmacotherapy for Mother and Infant

Area of Science:

• * Infectious Diseases
• * Maternal-Fetal Medicine
• * Pharmacology

Background:

• * Coronavirus disease 2019 (COVID-19) presents a spectrum of illness, from asymptomatic infection to fatal severe acute respiratory syndrome.
• * The global pandemic has spurred extensive research into effective treatments and vaccine development.
• * Understanding the impact of these interventions on pregnant populations is critical.

Purpose of the Study:

• * To review currently available treatments and vaccines for COVID-19.
• * To examine the application of these interventions in pregnant individuals.
• * To summarize available data on the effects of COVID-19 treatments on fetal development and neonates.

Main Methods:

• * Literature review of existing studies and clinical data.
• * Analysis of treatment protocols and vaccine efficacy in the context of pregnancy.
• * Evaluation of reported outcomes for fetal development and neonatal health.

Main Results:

• * A range of therapeutic options, including repurposed drugs and novel agents, are being explored for COVID-19.
• * Vaccination strategies are being adapted for pregnant individuals, with ongoing monitoring of safety and efficacy.
• * Data on the effects of specific treatments on fetal and neonatal outcomes are emerging but require further investigation.

Conclusions:

• * Current COVID-19 treatments and vaccines offer potential benefits but require careful consideration in pregnant populations.
• * Further research is essential to fully elucidate the long-term impacts on fetal development and neonates.
• * Evidence-based guidelines are crucial for managing COVID-19 in pregnant individuals.